
HighPeak Energy secured $450 million through convertible preferred stock at $1,000 per share, convertible at $9.50 per share, causing potential dilution. The company also obtained a bank line at a lower interest rate. A redemption feature on the preferred stock becomes exercisable after three years. The firm plans to use strong oil prices to pay down the bank line, while reported losses include a noncash hedging charge and higher commodity prices temporarily impact working capital.
HighPeak Energy’s refinancing is the subject, with this data for context. For readers following the energy sector, 60 of 79 US stocks on Pluang rose while 19 fell. Notable movers include HAL at USD 33.78 (+3.11%), PTEN at USD 10.97 (+2.81%), and ENPH at USD 26.07 (-2.65%). This snapshot is as of Nov 15, 2026 20:41 WIB.
More News

All patients in Alpha Tau’s glioblastoma trial alive with 100% tumor response and no serious side effects
Alpha Tau Medical announced interim results from its U.S. trial of Alpha DaRT therapy for recurrent glioblastoma, showing all eight treated patients are alive with a median follow-up of 6.9 months and no median survival reached. Among six patients as…

Spot Bitcoin ETFs offer cleaner exposure than Bitcoin treasury firms, says Castle Island Ventures partner
Nic Carter of Castle Island Ventures argues that spot Bitcoin ETFs provide investors with direct Bitcoin exposure without the added risks and costs of investing in Bitcoin treasury companies. These treasury firms, which hold Bitcoin as a core asset, …

BitMine faces $8.83B paper loss on Ethereum reserves amid volatile crypto market.
BitMine reportedly has an estimated $8.83 billion paper loss on its Ethereum holdings, based on an average purchase price from August applied to November’s larger reserves. This figure, however, is not an official loss as the additional Ethereum acqu…

Aero (AERO) plunges 27% in a week, underperforming Bitcoin and Ether losses.
Over the past week, the cryptocurrency Aero (AERO) experienced a significant drop of 27%, which is a larger decline compared to the losses seen in major cryptocurrencies Bitcoin (BTC) and Ether (ETH). This sharp decrease highlights increased volatili…

CVS says GLP-1 drugs could save health plans if priced below $350 monthly by reducing hospital visits.
CVS Health’s analysis of Aetna insurance data shows that GLP-1 drugs, used for obesity and diabetes, could help employers and health plans break even if priced under $350 per month. These drugs reduce emergency room visits by 10%-12% and hospitalizat…